Group-based Cognitive-behavioral Therapy for Adults With Attention-deficit/Hyperactivity Disorder Inattentive-type

Attention Deficit Disorder With Hyperactivity Clinical Trial

Official title:

Group-based Cognitive-behavioral Therapy for Adults With Attention-deficit/Hyperactivity Disorder Inattentive-type: a Pilot Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02889354
• Other study ID #: KI-2016/255-31/5
• Status: Completed
• Phase: N/A
• First received: August 31, 2016
• Last updated: August 22, 2017
• Start date: August 2016
• Est. completion date: June 2017

Study information

• Verified date: August 2017
• Source: Karolinska Institutet
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The newly developed CBT for ADHD inattentive-type (ADHD-I) protocol is tested for feasibility and acceptability in a pilot study with a single group design. The study also evaluates measurements and recruiting possibilities, and effects of the intervention. Research hypotheses include: 1. There is a basis for recruiting ADHD-I patients for participation in an RCT at psychiatric outpatient units, 2. The measurements in the study are feasible and reasonable in regards to patient characteristics; that is, the patients are responding to the questionnaires as intended, 3. The CBT for ADHD-I intervention is feasible in terms of treatment completion, compliance to home assignments, and credibility and relevance, and is lacking of or involves a tolerable degree of adverse effects, and 4. The CBT for ADHD-I protocol reduces core symptoms of ADHD-I as well as symptoms of stress, depression, and anxiety, and improves quality of life.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: June 2017
• Est. primary completion date: June 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

In addition to an ADHD inattentive-type diagnosis, inclusion criteria are:

1. 18 years or older,

2. intelligence quotient above 80-85, and

3. if on medication, it needs to be well-established since three months.

Exclusion Criteria:

1. autism spectrum disorder,

2. ongoing substance use disorder,

3. difficulties in compliance with medical or other treatment,

4. social and/or psychiatric problems to such an extent that it prevents focusing on treatment, or

5. ongoing cognitive-behavioral therapy.

Related Conditions & MeSH terms

• Attention Deficit Disorder With Hyperactivity
• Disease
• Hyperkinesis

Intervention

Behavioral:
• Cognitive-behavioral therapy

Locations

Country	Name	City	State
Sweden	Capio Psykiatri AB	Stockholm

Sponsors (1)

Lead Sponsor	Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Brown ADD Scales	Diagnostic measure	14 weeks